30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
Canada Biotechnology & Medical Research

Biovaxys Technology Corp (BIOV)

Track

Stock chart
Ticker: BIOV Exchange: CNX
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Passin, James
Director of Issuer, Senior Officer of Issuer
1 purchase — total 252,380 CAD
Buy 18 Nov 2025
Value CA$4,704,267.51 | Price 73.12 | Shares 17,981
Buy 28 Apr 2025
Value CA$3,655,401.03 | Price 251.92 | Shares 43,797
Buy 10 Jan 2025
Value CA$500,000.00 | Price 0.05 | Shares 10,000,000
Sale 6 Jan 2025
Value CA$503,000.00 | Price 0.05 | Shares 10,000,000
Buy 11 Sep 2024
Value CA$300,000.00 | Price 0.05 | Shares 6,000,000
Sale 6 Sep 2024
Value CA$300,000.00 | Price 0.06 | Shares 5,000,000
Buy 26 Jan 2024
Value CA$18,999.99 | Price 0.03 | Shares 633,333
Buy 14 Jul 2023
Value CA$2,500.00 | Price 0.03 | Shares 100,000
Buy 14 Jul 2023
Value US$2,685.00 | Price 0.02 | Shares 150,000
Buy 20 Sep 2022
Value CA$25,000.00 | Price 0.10 | Shares 250,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-20 2025-11-18 B Purchase
2.7
Passin, James

Director of Issuer, Senior Officer of Issuer

Executive Director
17,981 -19.3%
73.12
CA$4,704,268 		17,981 -19.3% 73.12 CA$4,704,268
2025-04-28 2025-04-28 B Purchase
2.7
Passin, James

Director of Issuer, Senior Officer of Issuer

Executive Director
43,797 -17.0%
251.92
CA$3,655,401 		43,797 -17.0% 251.92 CA$3,655,401
2025-01-13 2025-01-10 B Purchase
2.7
Passin, James

Director of Issuer, Senior Officer of Issuer

Executive Director
78,436 +30.1%
497.03
CA$3,952,709 		78,436 +30.1% 497.03 CA$3,952,709
2025-01-13 2025-01-06 S Sale
2.7
Passin, James

Director of Issuer, Senior Officer of Issuer

Executive Director
10,000,000 -52.1%
0.05
CA$503,000 		10,000,000 -52.1% 0.05 CA$503,000
2024-09-12 2024-09-11 B Purchase
2.7
Passin, James

Director of Issuer, Senior Officer of Issuer

Executive Director
6,000,000 +45.5%
0.05
CA$300,000 		6,000,000 +45.5% 0.05 CA$300,000
2024-09-12 2024-09-06 S Sale
2.7
Passin, James

Director of Issuer, Senior Officer of Issuer

Executive Director
5,000,000 -27.5%
0.06
CA$300,000 		5,000,000 -27.5% 0.06 CA$300,000
2024-01-31 2024-01-26 B Purchase
1.8
Kovan, Kenneth

Senior Officer of Issuer

Officer
633,333 +9.4%
0.03
CA$19,000 		633,333 +9.4% 0.03 CA$19,000
2023-07-14 2023-07-14 B Purchase
1.8
Kovan, Kenneth

Senior Officer of Issuer

Officer
100,000 +1.5%
0.03
CA$2,500 		100,000 +1.5% 0.03 CA$2,500
2023-07-14 2023-07-14 B Purchase
1.8
Kovan, Kenneth

Senior Officer of Issuer

Officer
150,000
0.02
US$2,685 		150,000 0.02 US$2,685
2022-09-20 2022-09-20 B Purchase
Passin, James Christopher

Director of Issuer, Senior Officer of Issuer

Executive Director
250,000 +1.9%
0.10
CA$25,000 		250,000 +1.9% 0.10 CA$25,000
Explore more

More insider trading research around Biovaxys Technology Corp

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America